State Street’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.31M | Buy |
1,234,473
+23,127
| +2% | +$62K | ﹤0.01% | 3115 |
|
2025
Q1 | $1.71M | Buy |
1,211,346
+23,152
| +2% | +$32.6K | ﹤0.01% | 3302 |
|
2024
Q4 | $2.36M | Buy |
1,188,194
+82,183
| +7% | +$164K | ﹤0.01% | 3262 |
|
2024
Q3 | $3.48M | Buy |
1,106,011
+114,715
| +12% | +$361K | ﹤0.01% | 3115 |
|
2024
Q2 | $3.13M | Buy |
+991,296
| New | +$3.13M | ﹤0.01% | 3128 |
|
2022
Q3 | – | Sell |
-14,028
| Closed | -$112K | – | 4932 |
|
2022
Q2 | $112K | Buy |
+14,028
| New | +$112K | ﹤0.01% | 4474 |
|